Once every two weeks, TheBodyPRO.com sends its subscribers an email newsletter highlighting some of the most noteworthy HIV/AIDS-related news and research headlines recently added to TheBodyPRO.com, as well as a selection of personal perspectives and patient-friendly materials from TheBody.com, TheBodyPRO.com's sister site geared toward the general HIV/AIDS community.
Below is an online archive of each of our email newsletters. If you'd like to sign up, just complete your free registration at TheBodyPRO.com. If you're an existing member and you'd like to modify your settings or unsubsribe from our email newsletters, please log in and modify your account information.
|Taking Atripla Three Days a Week Maintains Undetectable HIV Viral Load, Pilot Study Finds|
|Which HIV Treatment Regimens Are Recommended for Newly Diagnosed Patients?|
|Weekly PRO 140 Antibody Injections May Work as HIV Maintenance Therapy|
|This Week in HIV Research: Effects of Treatment on Arterial Inflammation; Mortality Rate After 5 Years of Treatment Not Impacted by Initial CD4 Count|
|Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study|